Study type

Study topic

Disease /health condition
Human medicinal product

Study type

Non-interventional study

Scope of the study

Assessment of risk minimisation measure implementation or effectiveness

Data collection methods

Secondary use of data
Non-interventional study

Non-interventional study design

Systematic review and meta-analysis
Study drug and medical condition

Anatomical Therapeutic Chemical (ATC) code

(J07BM02) papillomavirus (human types 16, 18)
papillomavirus (human types 16, 18)

Medical condition to be studied

Autoimmune thyroiditis
Guillain-Barre syndrome
Inflammatory bowel disease
Population studied

Short description of the study population

Female subjects aged 9 years and above who had received Cervarix Vaccine.

Age groups

  • Paediatric Population (< 18 years)
    • Adolescents (12 to < 18 years)
  • Adult and elderly population (≥18 years)
    • Adults (18 to < 65 years)
      • Adults (18 to < 46 years)

Estimated number of subjects

1
Study design details

Main study objective

This study will estimate the overall risk of developing three autoimmune diseases (autoimmune thyroiditis, Guillain Barre Syndrome and Inflammatory Bowel diseases) following Cervarix vaccination in females.

Outcomes

Occurrence of cases of autoimmune thyroiditis, Guillain-Barré Syndrome, and Inflammatory Bowel Disease during 2 years after the first dose of Cervarix.

Data analysis plan

Meta-analysis method with continuity correction. A continuity correction will be applied to all studies to overcome the single- and double- zero issue. Various continuity corrections have been proposed: constant continuity correction k (for example k=0.5 is commonly used in many software’s), continuity correction reciprocal of the opposite treatment arm size, empirical continuity correction.Advantage of this method is that all studies can be included, and any metaanalysis calculation method (inverse variance-weighted method, Peto’s method, Mantel-Haenszel’s method, etc.) can be applied, all individual studies can also be depicted in forest plots, and heterogeneity among studies can be estimated and tested.